Lessons from Ukraine: Bringing Next-Generation Molecular TB Diagnostics to the Frontlines Read more Tuberculosis Kills More People Than Any Other Infection. Here’s How We’re Building the Company to Change That. Read more Contract Manufacturing: Blending Agility with Speed to Market Read more Uganda’s TB Progress Highlights a Critical Lesson: Diagnostics Need Strong Health Systems Read more The Cost of Silence: Why Early Detection is the Only Way to Stop Ebola Read more Bridging the Global TB Diagnostic Gap: The Clinical Rigor Behind EMPE TBDx Read more Advancing Healthcare Diagnostics: Why Rwanda is the New Frontier for TB Innovation Read more From Innovation to Access: Bridging the Last-Mile Gap in TB Diagnostics Read more Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR‑TB test Read more Tuberculosis Diagnostics Pipeline Report 2025 Read more Novel diagnostic test for the detection of Mycobacterium tuberculosis and its resistance to rifampicin, isoniazid, and fluoroquinolones directly in sputum samples Read more WHO Global TB Report 2023 Read more 1 2
